Bracket: PE investment to support growth, innovation

By Melissa Fassbender contact

- Last updated on GMT

Bracket: PE investment to support growth, innovation

Related tags: Investment

The private equity firm, Genstar capital, has acquired the clinical trial technology and specialty services provider, Bracket.

Jeff Kinell, Bracket’s CEO, told us the company is “very excited​” about the opportunity.

Genstar has a great track record in this area, and we think they will be a great partner for us​," he added.

Genstar's current and previous investments in healthcare technology and services companies include ERT, ConnectiveRx, Netsmart, and PRA International.

"Genstar brings experience and stability. With Genstar's backing, we can proceed with growth investments and strategic acquisitions to expand our product capabilities,” ​Kinell said. “This will allow us to continue to innovate in our technology development, something our clients have come to expect​."

Moving forward, the company structure, management team, employees, and offices are all “staying the course​,” Kinell explained, though the company has plans for growth and hiring at all of its locations this year. Ultimately, “this transition should be largely unnoticeable to both employees and clients​," he said.

Related topics: Clinical Development, Data management

Related news

Show more

Related products

Local Lab Data Management

Local Lab Data Management

Q2 Solutions | 01-Jul-2020 | Technical / White Paper

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Related suppliers

Follow us

Products

View more

Webinars